WHDH-TV | Pfizer ends development of key cholesterol drug Khaleej Times - NEW YORK - In a surprising setback for the worldâs largest drugmaker Pfizer Inc. halted development on Saturday of its top experimental medicine the cholesterol drug torcetrapib due to safety concerns. Pfizer's changing of the guard bad news for Pfizer "good cholesterol" drug pulled due to ... |